Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings

BACKGROUND: Vaginal rings (VR) containing antiretroviral (ARV) drugs can be utilized for prevention of human immunodeficiency virus (HIV) with potential for improved adherence compared to daily pills. Combination ARV VRs could improve efficacy. METHODS: MTN-027, a single-blind, randomized, placebo-c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Main Authors: Hoesley, Craig J, Chen, Beatrice A, Anderson, Peter L, Dezzutti, Charlene S, Strizki, Julie, Sprinkle, Carol, Heard, Faye, Bauermeister, Jose, Hall, Wayne, Jacobson, Cindy, Berthiaume, Jennifer, Mayo, Ashley, Gundacker, Holly, Richardson-Harman, Nicola, Piper, Jeanna
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Articles and Commentaries
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424075/
https://ncbi.nlm.nih.gov/pubmed/30289435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy653
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares